The effect of pulmonary thromboendarterectomy (PTE) on dead space ventilation in patients with chronic thrombo embolic pulmonary hypertension (CTEPH)

N. E. Verhey, H. J. Reesink, J. J. Kloek, P. Bresser, C. M. Roos (Amsterdam, The Netherlands)

Source: Annual Congress 2004 - Lung function technology: beyond the basic test
Session: Lung function technology: beyond the basic test
Session type: Thematic Poster Session
Number: 2498
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. E. Verhey, H. J. Reesink, J. J. Kloek, P. Bresser, C. M. Roos (Amsterdam, The Netherlands). The effect of pulmonary thromboendarterectomy (PTE) on dead space ventilation in patients with chronic thrombo embolic pulmonary hypertension (CTEPH). Eur Respir J 2004; 24: Suppl. 48, 2498

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development
Source: Eur Respir J 2003; 22: Suppl. 45, 221s
Year: 2003

Accuracy of pre-operative specimen level prediction in chronic thromboembolic pulmonary hypertension (CTEPH) patients undergoing pulmonary thromboendarterectomy (PTE)
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)?
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Long-term outcomes of pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2007; 30: Suppl. 51, 603s
Year: 2007

The course of chronic thromboembolic pulmonary hypertension (CTEPH) in anticoagulated patients not eligible for pulmonary endarterectomy
Source: Eur Respir J 2002; 20: Suppl. 38, 237s
Year: 2002

Chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 637-648
Year: 2004



Balloon pulmonary angioplasty (BPA) for inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Pulmonary artery pulse pressure in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2006; 28: Suppl. 50, 399s
Year: 2006

Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005

Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Chronic thromboembolic pulmonary hypertension (CTEPH) and beyond
Source: Annual Congress 2011 - Ceremony for Pulmonary Arterial Hypertension Award (supported by Actelion) followed by Pulmonary Hypertension in the Clinic Grand Round - an interactive session
Year: 2011


Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 595-600
Year: 2004



Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009


Medical treatment in persistent pulmonary hypertension after pulmonary thrombendarterectomy in patients with chronic thrombembolic pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 364s
Year: 2006

Mismatch of major vessel obstruction and pulmonary vascular resistance (PVR) in chronic thromboembolic pulmonary hypertension (CTEPH) with associated medical conditions (AMC)
Source: Eur Respir J 2006; 28: Suppl. 50, 402s
Year: 2006

Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Is there a fixed relationship between the mean and systolic pulmonary artery pressures in idiopathic pulmonary arterial hypertension (IPAH) and proximal chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009